Ginsenoside Rb1 ameliorates post-doxorubicin treatment myocardial hypertrophy via CaN/NFATc4/GATA4
Release time:
1970-01-01
Chang JJ, Xu LX, Yi WJ, Zhang HH, Zhang JW, Zheng B, Fu PY, He RL, Wang RX, Jiang JF, Gui LX, Wu MX, Lin JJ, Huang ZH, Song JL, Lin MJ, Jiao HX, Wu ZJ. Ginsenoside Rb1 ameliorates post-doxorubicin treatment myocardial hypertrophy via CaN/NFATc4/GATA4. J Ginseng Res. 2025 Sep;49(5):585-593.doi: 10.1016/j.jgr.2025.06.003.
Activity Center